Children and TB pharmacokinetics: no longer in infancy?

Eur Respir J. 2023 Mar 9;61(3):2202003. doi: 10.1183/13993003.02003-2022. Print 2023 Mar.

Author

Justin T Denholm^{1

2}

Affiliations

¹ Victorian Tuberculosis Program, Melbourne, Australia justin.denholm@mh.org.au.
² Department of Infectious Diseases, University of Melbourne, Parkville, Australia.

PMID: 36894189
DOI: 10.1183/13993003.02003-2022

No abstract available

Publication types

Editorial
Comment

MeSH terms

Adolescent
Antitubercular Agents* / pharmacokinetics
Antitubercular Agents* / therapeutic use
Child
Humans
Infant
Isoniazid / pharmacokinetics
Rifampin* / pharmacokinetics

Substances

Antitubercular Agents
Rifampin
Isoniazid